These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans. Le Corre P; Gibassier D; Sado P; Le Verge R Drug Metab Dispos; 1988; 16(6):858-64. PubMed ID: 2907466 [TBL] [Abstract][Full Text] [Related]
3. The influence of age and smoking on the elimination of disopyramide. Bonde J; Pedersen LE; Bødtker S; Angelo HR; Svendsen TL; Kampmann JP Br J Clin Pharmacol; 1985 Nov; 20(5):453-8. PubMed ID: 4074615 [TBL] [Abstract][Full Text] [Related]
4. Enantioselective steady-state kinetics of unbound disopyramide and its dealkylated metabolite in man. Hasselström J; Enquist M; Hermansson J; Dahlqvist R Eur J Clin Pharmacol; 1991; 41(5):481-4. PubMed ID: 1761078 [TBL] [Abstract][Full Text] [Related]
5. Does alpha 1-acid glycoprotein reduce the unbound metabolic clearance of disopyramide in patients with renal impairment? Braun J; Sörgel F; Gluth WP; Oie S Eur J Clin Pharmacol; 1988; 35(3):313-7. PubMed ID: 3181285 [TBL] [Abstract][Full Text] [Related]
7. Disopyramide pharmacokinetics in the elderly after single oral administration. Roberto P; Vitaliano B; Donatella P; Raffaella M; Sergio B; Gabriella C Pharmacol Res Commun; 1988 Dec; 20(12):1025-34. PubMed ID: 3211990 [TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans. Aitio ML; Allonen H; Kanto J; Mäntylä R Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):219-26. PubMed ID: 7095921 [TBL] [Abstract][Full Text] [Related]
9. Effects of serum concentrations of disopyramide and its metabolite mono-N-dealkyldisopyramide on the anticholinergic side effects associated with disopyramide. Tsuchishita Y; Fukumoto K; Kusumoto M; Ueno K Biol Pharm Bull; 2008 Jul; 31(7):1368-70. PubMed ID: 18591776 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a pharmacokinetic interaction between remacemide hydrochloride and phenobarbitone in healthy males. Hooper WD; Eadie MJ; Blakey GE; Lockton JA; Manun'Ebo M Br J Clin Pharmacol; 2001 Mar; 51(3):249-55. PubMed ID: 11298071 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients. Aso R; Ohashi K; Katoh T; Ogata H Int J Clin Pharmacol Res; 2001; 21(3-4):137-46. PubMed ID: 12067143 [TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal dialysis of disopyramide in healthy subjects. Arimori K; Kawano H; Nakano M Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):280-4. PubMed ID: 2737797 [TBL] [Abstract][Full Text] [Related]
15. Accumulation of a disopyramide metabolite in renal failure. Inagaki Y; Amano I; Otsu T ASAIO J; 1993; 39(3):M609-13. PubMed ID: 8268610 [TBL] [Abstract][Full Text] [Related]
16. Influence of concentration-dependent protein binding on serum concentrations and urinary excretion of disopyramide and its metabolite following oral administration. Haughey DB; Lima JJ Biopharm Drug Dispos; 1983; 4(2):103-12. PubMed ID: 6882879 [TBL] [Abstract][Full Text] [Related]
17. The effects of urine pH and plasma protein binding on the renal clearance of disopyramide. Cunningham JL; Shen DD; Shudo I; Azarnoff DL Clin Pharmacokinet; 1977; 2(5):373-83. PubMed ID: 21054 [TBL] [Abstract][Full Text] [Related]
18. Elimination kinetics and urinary excretion of disopyramide in human healthy volunteers. Bonde J; Jensen NM; Pedersen LE; Graudal NA; Angelo HR; Kampmann JP Pharmacol Toxicol; 1988 May; 62(5):298-301. PubMed ID: 3413032 [TBL] [Abstract][Full Text] [Related]
19. Relationship between alpha 1-acid glycoprotein and distribution of disopyramide and mono-N-dealkyldisopyramide in whole blood. Bredesen JE; Kierulf P Br J Clin Pharmacol; 1986 Sep; 22(3):281-6. PubMed ID: 3768240 [TBL] [Abstract][Full Text] [Related]
20. Relationship between the therapeutic effects or side-effects and the serum disopyramide or mono-N-dealkylated disopyramide concentration after repeated oral administration of disopyramide to arrhythmic patients. Masuhara K; Ohno T; Hamaguchi K; Katoh K; Kashiwada K; Takahashi S; Tanaka Y; Someya K; Ogata H Int J Clin Pharmacol Res; 1995; 15(3):103-13. PubMed ID: 8847151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]